Systems and methods for controlling inflammatory response

US10080690B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10080690-B2
Application numberUS-201615069703-A
CountryUS
Kind codeB2
Filing dateMar 14, 2016
Priority dateSep 18, 2008
Publication dateSep 25, 2018
Grant dateSep 25, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A method and system for controlling inflammatory response at an internal tissue site of a patient utilizes a reduced-pressure treatment device. Controlling the inflammatory response may be accomplished in a number of ways that involve treating the inflammatory milieu. Treating the inflammatory milieu may include removing or moderating pro-inflammatory stimuli, e.g., fluids, enhancing perfusion of the tissue at or near the internal tissue site, or providing reduced-pressure therapy. The reduced-pressure treatment device is placed at or near the internal tissue site and is fluidly coupled to an external reduced-pressure source. The reduced-pressure treatment device provides reduced pressure proximate the tissue site and treats the inflammatory milieu. The reduced-pressure treatment device for controlling inflammatory response may be a minimally-invasive treatment device.

First claim

Opening claim text (preview).

We claim: 1. A treatment device, comprising: a first leg manifold member; a second leg manifold member intersecting the first leg manifold member to form a central connection site; an encapsulating envelope encapsulating the first leg manifold member and the second leg manifold member; a plurality of fenestrations formed on the encapsulating envelope; and a connecting interface coupled to the central connection site and fluidly coupled to the first leg manifold member and the second leg manifold member; wherein the first leg manifold member and the second leg manifold member form two obtuse angles and two acute angles. 2. The treatment device of claim 1 , further comprising a sealing member operable to form a pneumatic seal over an internal tissue site. 3. The treatment device of claim 1 , wherein the first leg manifold member and the second leg manifold member each comprises a tapered end adapted for insertion through a trocar. 4. A system, comprising: a treatment device configured to be disposed at an internal tissue site, comprising: a leg manifold member comprising a foam; an encapsulating envelope encapsulating the leg manifold member; and a plurality of fenestrations formed on the encapsulating envelope; a sealing member adapted to be disposed over the treatment device; and a reduced-pressure interface adapted to be coupled to the encapsulating envelope in fluid communication with the leg manifold member. 5. The system of claim 4 , wherein the leg manifold member has an aspect ratio of at least 1.5 and not greater than 6.0. 6. The system of claim 4 , further comprising a reduced-pressure delivery conduit having a first end coupled to the reduced-pressure interface and a second end coupled to a quick connection fitting. 7. The system of claim 4 , wherein the leg manifold member is symmetrical about a major axis of the leg manifold member. 8. The system of claim 4 , wherein the leg manifold member comprises a tapered end adapted for insertion through a trocar. 9. The system of claim 4 , further comprising a pressure transducer within the leg manifold member. 10. The system of claim 4 , wherein: the leg manifold member has an aspect ratio that is not greater than 6.0; the leg manifold member is symmetrical about a major axis of the leg manifold member; and the leg manifold member comprises a tapered end adapted for insertion through a trocar. 11. The system of claim 4 , further comprising a second leg manifold member intersecting the leg manifold member to form a central connection site. 12. The system of claim 4 , further comprising a second leg manifold member intersecting the leg manifold member to form two obtuse angles and two acute angles.

Assignees

Inventors

Classifications

  • with fluid retention members · CPC title

  • Assembling or joining · CPC title

  • Abdomen bandages or bandaging garments · CPC title

  • Abdominal cavity · CPC title

  • Implant devices for drainage of body fluids from one part of the body to another (intraocular A61F9/00781; middle ear A61F11/202) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10080690B2 cover?
A method and system for controlling inflammatory response at an internal tissue site of a patient utilizes a reduced-pressure treatment device. Controlling the inflammatory response may be accomplished in a number of ways that involve treating the inflammatory milieu. Treating the inflammatory milieu may include removing or moderating pro-inflammatory stimuli, e.g., fluids, enhancing perfusion …
Who is the assignee on this patent?
Kci Licensing Inc
What technology area does this patent fall under?
Primary CPC classification A61M1/915. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Sep 25 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 4 related publications on this page (citations in our corpus or others sharing the same primary CPC).